StonvexLoading…
StonvexStonvexStonvexCore line items from MSTR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $477.23M | $463.46M | $496.26M | $499.26M |
Operating Income | $-5.44B | $-1.85B | $-115.05M | $-1.28B |
Net Income | $-3.85B | $-1.17B | $429.12M | $-1.47B |
EPS (Diluted) | $-15.23 | $-6.06 | $2.64 | $-12.98 |
Total Assets | $61.64B | $25.84B | $4.76B | $2.41B |
Total Liabilities | $10.60B | $7.61B | $2.60B | $2.79B |
Cash & Equivalents | $2.30B | $38.12M | $46.82M | $43.84M |
Free Cash Flow OCF − CapEx | $-75.45M | $-56.01M | $9.77M | $725.00K |
Shares Outstanding | 277.66M | 192.55M | 165.66M | 113.21M |